108 related articles for article (PubMed ID: 27029791)
1. Pin1 is related with clinical stage of papillary thyroid carcinoma.
Jiang L; Chu H; Zheng H
World J Surg Oncol; 2016 Mar; 14():95. PubMed ID: 27029791
[TBL] [Abstract][Full Text] [Related]
2. Expression of HIF-1α and HIF-2α correlates to biological and clinical significance in papillary thyroid carcinoma.
Liu YM; Ying SP; Huang YR; Pan Y; Chen WJ; Ni LQ; Xu JY; Shen QY; Liang Y
World J Surg Oncol; 2016 Feb; 14(1):30. PubMed ID: 26846782
[TBL] [Abstract][Full Text] [Related]
3. Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma.
Dencic TM; Savin SB; Selemetjev SA; Paskas SD; Zivaljevic VR; Bozic VD; Cvejic DS
Pathol Oncol Res; 2015 Jul; 21(3):735-42. PubMed ID: 25577274
[TBL] [Abstract][Full Text] [Related]
4. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
[TBL] [Abstract][Full Text] [Related]
5. Expression of cancer-associated fibroblast-related proteins in thyroid papillary carcinoma.
Sun WY; Jung WH; Koo JS
Tumour Biol; 2016 Jun; 37(6):8197-207. PubMed ID: 26715280
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 overexpression in thyroid tumours from a radio-contaminated area and its correlation with Pin1 and aberrant beta-catenin expression.
Nakashima M; Meirmanov S; Naruke Y; Kondo H; Saenko V; Rogounovitch T; Shimizu-Yoshida Y; Takamura N; Namba H; Ito M; Abrosimov A; Lushnikov E; Roumiantsev P; Tsyb A; Yamashita S; Sekine I
J Pathol; 2004 Apr; 202(4):446-55. PubMed ID: 15095272
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of Hu-Antigen Receptor (HuR) and Cyclooxygenase-2 (COX-2) Expression in Human Malignant and Benign Thyroid Lesions.
Giaginis C; Alexandrou P; Delladetsima I; Karavokyros I; Danas E; Giagini A; Patsouris E; Theocharis S
Pathol Oncol Res; 2016 Jan; 22(1):189-96. PubMed ID: 26498465
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of RET/PTC expression in papillary thyroid carcinoma and its correlation with prognostic factors in a north Indian population.
Mishra A; Agrawal V; Krishnani N; Mishra SK
J Postgrad Med; 2009; 55(3):171-5. PubMed ID: 19884740
[TBL] [Abstract][Full Text] [Related]
9. The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence.
Tanaka K; Kurebayashi J; Sohda M; Nomura T; Prabhakar U; Yan L; Sonoo H
Thyroid; 2009 Jan; 19(1):21-5. PubMed ID: 19072670
[TBL] [Abstract][Full Text] [Related]
10. Expression of BMP-4 in papillary thyroid carcinoma and its correlation with tumor invasion and progression.
Meng X; Zhu P; Li N; Hu J; Wang S; Pang S; Wang J
Pathol Res Pract; 2017 Apr; 213(4):359-363. PubMed ID: 28214211
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of HGF and c-MET is associated with subclinical central lymph node metastasis in papillary thyroid microcarcinoma.
Koo BS; Kim JM; Seo ST; Yoon YH; Kwon KR; Kim SH; Kwon HW; Bae WJ; Lim YC
Ann Surg Oncol; 2014 Jul; 21(7):2310-7. PubMed ID: 24562934
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
[TBL] [Abstract][Full Text] [Related]
14. Implication of intracellular localization of transcriptional repressor PLZF in thyroid neoplasms.
Matsuzawa K; Izawa S; Ohkura T; Ohkura H; Ishiguro K; Yoshida A; Takiyama Y; Haneda M; Shigemasa C; Yamamoto K; Taniguchi S
BMC Endocr Disord; 2014 Jul; 14():52. PubMed ID: 24990570
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8.
Fang W; Ye L; Shen L; Cai J; Huang F; Wei Q; Fei X; Chen X; Guan H; Wang W; Li X; Ning G
Carcinogenesis; 2014 Aug; 35(8):1780-7. PubMed ID: 24608042
[TBL] [Abstract][Full Text] [Related]
16. Expression of PIN1 in Gastrointestinal Stromal Tumours and its Clinical Significance.
Jiang L; Cao M; Hu J; Chen J
Anticancer Res; 2016 Mar; 36(3):1275-80. PubMed ID: 26977025
[TBL] [Abstract][Full Text] [Related]
17. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.
Ayala G; Wang D; Wulf G; Frolov A; Li R; Sowadski J; Wheeler TM; Lu KP; Bao L
Cancer Res; 2003 Oct; 63(19):6244-51. PubMed ID: 14559810
[TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of FOXE1 in papillary thyroid carcinoma.
Fan Y; Ding Z; Yang Z; Deng X; Kang J; Wu B; Zheng Q
Mol Med Rep; 2013 Jul; 8(1):123-7. PubMed ID: 23715628
[TBL] [Abstract][Full Text] [Related]
19. Expression of Bax, p53, and p27/kip in patients with papillary thyroid carcinoma with or without cervical nodal metastasis.
Karlidag T; Cobanoglu B; Keles E; Alpay HC; Ozercan I; Kaygusuz I; Yalcin S; Sakallioglu O
Am J Otolaryngol; 2007; 28(1):31-6. PubMed ID: 17162129
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
